Table I.
Data presented as mean ± standard deviation, or as % (n) unless otherwise indicated.
| Variable | PH group (n=15) | Non-PH group (n=10) | P-value |
|---|---|---|---|
| Age, years | 70.70±7.20 | 55.70±11.80 | 0.008 |
| Female, n (%) | 9 (60) | 4 (6) | 0.900 |
| Height, cm | 168.00±9.60 | 171.00±13.00 | 0.900 |
| Weight, kg | 68.00±12.00 | 76.00±17.00 | 0.700 |
| Body surface area, m2 | 1.78±0.90 | 1.90±0.70 | 0.900 |
| Body-mass index | 23.00±3.80 | 25.40±3.80 | 0.800 |
| COPD, n (%) | 0 (0) | 0 (0) | |
| Diabetes mellitus, n (%) | 3 (20) | 0 (0) | 0.050 |
| Creatinine (mg/dl) | 1.01±0.80 | 0.67±0.40 | 0.700 |
| Chronic atrial fibrillation, n (%) | 8 (53) | 2 (20) | 0.020 |
| PAVD, n (%) | 1 (6.6) | 0 (0) | 0.800 |
| Stroke incident, n (%) | 0 (0) | 0 (0) | |
| Arterial hypertension, n (%) | 8 (53) | 5 (50) | 0.900 |
| NYHA class III–IV, n (%) | 5 (38) | 0 (0) | 0.030 |
| LVEF, % | 47.00±0.14 | 60.00±0.50 | 0.007 |
PH, pulmonary hypertension; COPD, chronic obstructive pulmonary disease, PAVD, peripheral arterial venous disease; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction.